A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
作者信息
Temel M, Atagündüz P, Direskeneli H
出版信息
Ann Rheum Dis. 2005 Sep;64(9):1383-4. doi: 10.1136/ard.2004.028423.
Abstract
摘要
相似文献
1
A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.在三级临床护理中接受随访的强直性脊柱炎患者的一个主要亚组，根据当前指南需要抗肿瘤坏死因子α生物治疗。
Ann Rheum Dis. 2005 Sep;64(9):1383-4. doi: 10.1136/ard.2004.028423.
2
Established criteria for disease controlling drugs in ankylosing spondylitis.强直性脊柱炎疾病控制药物的既定标准。
Ann Rheum Dis. 2003 Sep;62(9):793-4. doi: 10.1136/ard.62.9.793.
3
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.一项关于在强直性脊柱炎中开始使用肿瘤坏死因子阻断剂的国际研究。
Ann Rheum Dis. 2006 Dec;65(12):1620-5. doi: 10.1136/ard.2005.042630. Epub 2006 Feb 7.
4
Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.强直性脊柱炎的抗肿瘤坏死因子治疗。需要指南。
Rheumatology (Oxford). 2003 Mar;42(3):490. doi: 10.1093/rheumatology/keg113.
5
The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.强直性脊柱炎患者对抗肿瘤坏死因子（抗TNF）治疗的未满足需求。
Rheumatology (Oxford). 2005 Oct;44(10):1277-81. doi: 10.1093/rheumatology/keh713. Epub 2005 Aug 16.
6
BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.英国风湿病学会关于成人强直性脊柱炎患者使用肿瘤坏死因子-α阻滞剂的处方指南。英国风湿病学会工作组报告
Rheumatology (Oxford). 2005 Jul;44(7):939-47. doi: 10.1093/rheumatology/keh669. Epub 2005 May 18.
7
Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.对脊柱关节炎患者进行肿瘤坏死因子α阻断治疗的评估。
Rheumatology (Oxford). 2005 Jan;44(1):17-23. doi: 10.1093/rheumatology/keh358. Epub 2004 Aug 24.
8
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.关于在强直性脊柱炎患者中使用抗TNF药物的国际ASAS共识声明的首次更新。
Ann Rheum Dis. 2006 Mar;65(3):316-20. doi: 10.1136/ard.2005.040758. Epub 2005 Aug 11.
9
Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis.强直性脊柱炎的进展与当前药物治疗建议
Expert Opin Pharmacother. 2006 May;7(7):869-83. doi: 10.1517/14656566.7.7.869.
10
The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis.
Rheumatology (Oxford). 2007 Jun;46(6):1044-5. doi: 10.1093/rheumatology/kem065. Epub 2007 Mar 31.
Zotero 插件